USATODAY – A Food and Drug Administration advisory committee is holding an all-day meeting meeting Friday to review the data on Johnson & Johnson’s candidate vaccine and is likely to give the vaccine a thumbs-up, leading to an expected FDA authorization for the shot in adults within the next few days. An FDA report released early Wednesday deemed it safe and effective. Johnson & Johnson has agreed to provide 100 million doses of its vaccine in the U.S. by June, including 20 million by the end of March.
Continue Reading at USATODAY
World on the Run | Jo Lee Magazine
